Skip to the page

Data / Form D filings / Enterin, Inc.

Enterin, Inc.: Form D filings

Enterin, Inc., a biotechnology company in Philadelphia, PA, filed 6 Form D notices with the SEC between 2017 and 2023. The latest, on December 6, 2023, reports $5.1 million sold of a $20 million offering to 4 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2005 MARKET STREET, SUITE 3125, Philadelphia, PA, 19103
Phone
(215) 372-8031
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1711351

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Dec 6, 2023New notice$19,999,973$5,099,772$14,900,2014Nov 21, 2023sec.gov
Sep 12, 2022New notice$20,000,000$6,000,000$14,000,0003Aug 30, 2022sec.gov
Oct 8, 2021New notice$32,000,000$5,685,438$26,314,5622Sep 23, 2021sec.gov
Sep 16, 2020New notice$19,999,941$11,703,493$8,296,4489Sep 8, 2020sec.gov
Jan 28, 2019New notice$25,000,000$16,699,970$8,300,0306Jan 11, 2019sec.gov
Jul 14, 2017New notice$12,717,276$5,467,272$7,250,00421Jun 30, 2017sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Michael ZasloffDirector
David McCulloughExecutive Officer, Director
Barry A MillerDirector
Don A MunozDirector
Katherine A WolfExecutive Officer
Richard A LarsonExecutive Officer
Roger A MillsDirector
William A KinneyExecutive Officer
Jay A BrammerDirector
Richard A PropperDirector
Mark A FinnDirector

Other biotechnology companies in Pennsylvania that filed recently

Every Form D from the week of Dec 4, 2023 · All recent filings in Pennsylvania · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Enterin, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.